Nuvama Bets on 4 Growth Stocks Amid Cost Pressures

BROKERAGE-REPORTS
Whalesbook Logo
AuthorRiya Kapoor|Published at:
Nuvama Bets on 4 Growth Stocks Amid Cost Pressures
Overview

Nuvama Institutional Equities is bullish on Fortis Healthcare, JK Cements, Century Plyboards, and Indigo Paints, anticipating strong growth and expansion to drive long-term gains. However, these companies face significant challenges from increasing input costs and global instability, potentially impacting profit margins.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Growth Over Margins: Nuvama's Strategy

Nuvama has reaffirmed its 'Buy' ratings for Fortis Healthcare, JK Cements, Century Plyboards, and Indigo Paints, favoring companies focused on expanding their operations and scale. This optimism comes as Indian industries grapple with rising crude oil prices, which increase logistics and energy costs. Sectors like cement and paints are particularly vulnerable to squeezed operating margins. While Nuvama emphasizes long-term growth factors, these companies must now contend with inflation that could slow down expected profit increases.

Sector-Specific Challenges and Strengths

Fortis Healthcare is expected to perform well, supported by a shortage of quality hospital beds and its Agilus diagnostics unit. Despite strong growth in revenue per occupied bed, hospital chains are not immune to rising costs affecting insurance and patient affordability. JK Cements and Century Plyboards are investing in new capacity to gain market share. However, the cement industry faces headwinds in FY27 due to higher petcoke and coal prices impacting profits. Current industry trends suggest that profit margin growth might be limited by price competition and volatile fuel costs.

Key Risks for Investors

Investors should be aware of the risks that could prevent these stocks from reaching their targets. For cement and building material companies, the ability to sustain price increases is crucial. Projections suggest that higher power and freight costs could reduce EBITDA per tonne by 10% to 15% next year. The hospital sector may also face increased scrutiny over patient costs and medical device pricing, potentially impacting margins. Aggressive expansion by management also carries execution risks and high borrowing costs, which could lead to significant profit shortfalls if not managed carefully during an economic slowdown.

Future Outlook and Market View

Despite these potential issues, the general market view remains positive, driven by India's domestic demand from infrastructure projects and growing consumer spending. The next two quarters will be critical for these companies. Their success in passing on raw material cost increases without losing sales volume will determine if the predicted 18% to 45% upside targets can be achieved.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.